4/A
Changes in Ownership
CLOVER HEALTH INVESTMENTS, CORP. /DE Filed Acc 0001801170-25-000170
CEO, Counterpart Health sold 15,203 shares at $3.26 ($49,562)
- CEO, Counterpart Health acquired 379,866 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wai Conrad CEO, Counterpart Health | 2024-09-13 | Grant or award 10b5-1 | +379,866 | 1,699,767 | D: show line 1 in the form | ||
| Wai Conrad CEO, Counterpart Health | 2025-07-08 | Sale 10b5-1 | −15,203 | $3.26 | $49,562 | 1,613,498 | I: show line 2 in the form |
| Open-market sales · 15,203 sh · avg $3.26 · $49,562 | |||||||
Loading xslF345X05/wk-form4a_1752189870.xml…